| STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma F Skoulidis, ME Goldberg, DM Greenawalt, MD Hellmann, MM Awad, ... Cancer discovery 8 (7), 822-835, 2018 | 1325 | 2018 |
| Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location JA Bufill Annals of internal medicine 113 (10), 779-788, 1990 | 916 | 1990 |
| Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors GM Frampton, SM Ali, M Rosenzweig, J Chmielecki, X Lu, TM Bauer, ... Cancer discovery 5 (8), 850-859, 2015 | 761 | 2015 |
| Diverse EGFR exon 20 insertions and co-occurring molecular alterations identified by comprehensive genomic profiling of NSCLC JW Riess, DR Gandara, GM Frampton, R Madison, N Peled, JA Bufill, ... Journal of Thoracic Oncology 13 (10), 1560-1568, 2018 | 234 | 2018 |
| Pulmonary sarcomatoid carcinomas commonly harbor either potentially targetable genomic alterations or high tumor mutational burden as observed by comprehensive genomic profiling AB Schrock, SD Li, GM Frampton, J Suh, E Braun, R Mehra, SC Buck, ... Journal of Thoracic Oncology 12 (6), 932-942, 2017 | 171 | 2017 |
| Phenotypic expression of disease in families that have mutations in the 5′ region of the adenomatous polyposis coli gene FM Giardiello, JD Brensinger, MC Luce, GM Petersen, MC Cayouette, ... Annals of internal medicine 126 (7), 514-519, 1997 | 119 | 1997 |
| Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors. Cancer Discov. 2015; 5: 850–859 … GM Frampton, SM Ali, M Rosenzweig, J Chmielecki, X Lu, TM Bauer, ... Go to original source... Go to PubMed, 2015 | 113 | 2015 |
| Hereditary Desmoid Disease in a Family with a Germline Alu I Repeat Mutation of the APC Gene KC Halling, CR Lazzaro, R Honchel, JA Bufill, SM Powell, CAS Arndt, ... Human heredity 49 (2), 97-102, 1999 | 86 | 1999 |
| Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101 EG Chiorean, R Ramasubbaiah, M Yu, J Picus, JA Bufill, Y Tong, ... The oncologist 17 (1), 13-e23, 2012 | 80 | 2012 |
| Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast … LI Wagner, F Zhao, PE Goss, JAW Chapman, LE Shepherd, TJ Whelan, ... Breast cancer research and treatment 169, 537-548, 2018 | 69 | 2018 |
| Pityrosporum folliculitis after bone marrow transplantation: clinical observations in five patients JA BUFILL, LG LUM, JG CAYA, CR CHITAMBAR, PS RITCH, ... Annals of internal medicine 108 (4), 560-563, 1988 | 58 | 1988 |
| Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsy G Li, D Pavlick, JH Chung, T Bauer, BA Tan, J Peguero, P Ward, A Kallab, ... Journal of Gastrointestinal Oncology 10 (5), 831, 2019 | 42 | 2019 |
| Randomized, double-blinded, multicenter, phase II study of pemetrexed, carboplatin, and bevacizumab with enzastaurin or placebo in chemonaive patients with stage IIIB/IV non … EM Casey, W Harb, D Bradford, J Bufill, S Nattam, J Patel, W Fisher, ... Journal of Thoracic Oncology 5 (11), 1815-1820, 2010 | 32 | 2010 |
| Yersinia enterocolitica serotype O:3 sepsis after blood transfusion. JA Bufill, PS Ritch | 29 | 1989 |
| Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer … EG Chiorean, S Sanghani, MA Schiel, M Yu, M Burns, Y Tong, DT Hinkle, ... Cancer chemotherapy and pharmacology 70, 25-32, 2012 | 27 | 2012 |
| Amyl nitrite-induced hemolytic anemia JC Brandes, JA Bufill, AV Pisciotta American Journal of Medicine 86 (2), 252-253, 1989 | 25 | 1989 |
| MA14. 01 Updated dataset assessing tumor mutation burden (TMB) as a biomarker for response to PD-1/PD-L1 targeted therapies in lung cancer (LC) A Schrock, N Sharma, N Peled, J Bufill, G Srkalovic, D Spigel, D Fabrizio, ... Journal of Thoracic Oncology 12 (1), S422, 2017 | 22 | 2017 |
| Intra-arterial chemotherapy for palliation of fungating breast cancer: a case report and review of the literature JA Bufill, WR Grace, R Neff American journal of clinical oncology 17 (2), 118-124, 1994 | 20 | 1994 |
| Colorectal cancer genetics. Closing the gap between genotype and phenotype JA Bufill Cancer 76 (12), 2389-2392, 1995 | 16 | 1995 |
| Age-related disease penetrance in a large medullary thyroid cancer family with a codon 609 RET gene mutation KC Halling, JA Bufill, M Cotter, SA Artz, AB Carpenter, D Schaid, ... Molecular Diagnosis 2 (4), 277-286, 1997 | 10 | 1997 |
